The Asia Dengue Summit 2016 will be held on the 13th to 14th January 2016 at Shangri-La Hotel in Bangkok, Thailand. The Asian Dengue Vaccination Advocacy (ADVA) Group, The Dengue Vaccine Initiative (DVI), the Southeast Asian Ministers of Education Organisation Tropical Medicine and Public Health Network (SEAMEO TROPMED) and the Fondation Mérieux (FMx) will be jointly organising this summit, which is focused on improving strategies for dengue prevention and management by educating stakeholders.
The two-day comprehensive scientific programme is divided into 4 sessions. The first session will provide an overview of dengue prevention and control across Asia and will include the World Health Organisation (WHO) perspective. The current profile of dengue vaccines in pipeline will also be highlighted. The session 2 will evaluate steps involved in planning for a dengue vaccination programme, with an entire talk dedicated to understanding the impact of mathematical modeling on vaccination strategies. The third session will talk about the policies undertaken for the implementation of new vaccine programmes in different Asian countries.
The last session will be dedicated to discuss and seek solutions to the practical issues for dengue programmes. The Asia Dengue Summit 2016 is designed to provide a very broad outlook of dengue management and control because the stakeholders include international organisations such as the World Health Organisation (WHO), the Partnership for Dengue Control (PDC), the Fondation Mérieux, the Dengue Vaccine Initiative (DVI), the International Vaccine Institute (IVI), the Asian Dengue Vaccination Advocacy (ADVA), the Southeast Asian Ministers of Education Organisation Tropical Medicine and Public Health Network (SEAMEO TROPMED) and the ASEAN Network for Drugs, Diagnostics, Vaccines and Traditional Medicines Innovation (ASEAN-NDI), among others.